Eden Biodesign And Onyvax Limited Announce Biomanufacturing Contract

4/6/2006 1:54:53 PM

Eden Biodesign, the operator of the UK National Biomanufacturing Centre (NBC), and Onyvax Limited, the biotechnology company developing novel cancer therapies, today announced a commercial agreement where Eden will supply cGMP clinical manufacturing services to Onyvax for its Cell Vaccine program in ovarian cancer.

Read at Company Press Release

Read Article at

Related Companies

News Categories

• Company Press Release

• Onyvax Limited

• Biotech/Pharma - Alliances